Best Obesity Doctor in Bangalore

Best Obesity Doctor in Bangalore

After his graduation in Medicine, he pursued his M.D in Internal Medicine from the prestigious Bangalore Medical College. Following this, he moved to the United Kingdom to pursue advanced and higher training in endocrinology, diabetology, and internal medicine. He has been successful in obtaining MRCP from Edinburgh and MRCP (Endocrinology) from the Royal College of Physicians London. He underwent extensive super speciality training in Endocrinology and Diabetology in various Internationally acclaimed university teaching hospitals in London, Manchester, Liverpool, and Scotland. Following this, he successfully obtained the Certificate of Completion of Specialist Training (CCST) from the Joint Royal College of Physicians Training Board in London, UK.

Training Courses Completion:

• King’s Fund Management Course (London)
• DAFNE Doctor Programme (Manchester)
• Fundamentals of Medical Leadership Course (Manchester)
• Community Diabetes Course (London)
• Clinical Endocrinology Update (Manchester)
• Advanced Insulin Pump Course (Bristol)
• Advanced Life support course (Blackburn)
• Teaching the Teachers Course (Manchester)
• Thyroid Ultrasound Course (London)
• Osteoporosis and Metabolic Bone Disease Course (Bristol)

Audit and Research work:

• Diabetes In-reach Inpatient audit Presented to Diabetes team, Aintree University Hospital, Liverpool
• Chest Drain Audit Presented at Royal Bolton Hospital in August, 2009
• Audit of Diabetes Ketoacidosis Management Presented at Blackpool Victoria Hospital in July, 2008
• G-CSF Use in the treatment of Infected Diabetic Foot Ulcers Presented at Royal Lancaster Infirmary in September, 2007
• Clinical Coding Audit  Presented at Royal Lancaster Infirmary in March, 2007
• PEG Tube Insertion Audit Presented at Royal Preston Hospital in January, 2005

Best Obesity Doctor in Bangalore

Areas of expertise of Dr. Manjunath are:

• Highly experienced endocrinologist & diabetologist trained in UK
• Management of complicated diabetes
• Management of endocrine conditions & cancers particularly thyroid & adrenal cancers
• Sports diabetes management
• Certified educator for DAFNE (Insulin Dose Adjustment For Normal Eating)
• Diagnosing & managing various types of diabetes including gestational diabetes
• Diabetes-related complications & various hormone abnormalities
• Expert in management of obesity & osteoporosis

Best Obesity Doctor in Bangalore

Dr. Manjunath Malige has been awarded the Fellowship of American College of Endocrinology.

Presentations - International:

• Diabetes – Recent advances in Diagnosis November 2015, Aintree University Teaching Hospital, Liverpool, U.K
• Inpatient Diabetes Management – Challenges and Strategies – Aintree University Teaching Hospital, January 2012
• Type 2 Diabetes – Recent advances in Management – November 2013, Royal Preston Hospital, Lancashire Teaching Hospitals, U.K
• GLP 1 analogues - For Who and Why? February 2013, Royal Preston Hospital, Lancashire Teaching Hospital, U.K
• Management of Complicated Diabetes – Wythenshawe University Hospital, Manchester, U.K
• Diabetes Foot Care – September 2012, Warrington Hospital, U.K
• PTHrP in the treatment of Primary Hyperparathyroidism – September 2010, Central Manchester Foundation Trust, Manchester, U.K
• Klinefelter Syndrome – Diagnosis and Management –August 2005, Royal Blackburn Hospital, U.K
• Presentation of study findings – Use of G-CSF in the treatment of diabetic foot ulcer- October 2005, Royal Lancaster Infirmary, Lancaster, UK
• Successful use of Thalidomide in the treatment of Adrenal Carcinoma – January 2006, Presented at Clinical Cases Meeting at the Royal Society of Medicine
• Presentation of Audit Data – Management of Diabetic Ketoacidosis in a District General Hospital (Blackpool Victoria Hospital ) – February 2008, Diabetes UK Annual Conference

Presentations - India:

• Designated Chief Speaker and session Moderator – Diabetes – Indian Perspective, complications and management – October 2016 – Indian Medical Association, Bangalore
• Diabetes for the common man – September 2016 – SAP Technologies Auditorium, Bangalore
• In Hospital Hyperglycemia Management – September 2016, Fortis Hospital, Bannerghatta Road, Bangalore
• Recent Advances in the Management of Diabetes – November 2016, Fortis Hospital, Bannerghatta Road, Bangalore.
• Hypoglycemia- common causes and appropriate management – Fortis Hospital, Bannerghatta Road, Bangalore
• Use of Basal Plus Insulin regime – Bangalore, January 2017
• DPP4 Inhibitors in Diabetes – KAPICON, Mysore May 2017
• Demystifying Vitamin D -  Fortis Hospital, October 2017
• Dulaglutide use in Type 2 Diabetes – Bangalore, January 2018
• Management of Thyroid Disorders in Pregnancy – Bangalore, March 2018
• SGLT2 Inhibitors and Heart Failure – Bangalore, June 2018
• Mixed Insulins – When and Where to use  - KRSSDI, Mysore Oct 2018
• Sulphonylureas and Diabetes – Time to revisit – Bangalore, January 2019
• Diuretics in Hypertension management – Pros and Cons – Bangalore March 2019

Poster Presentation:

• Glucagonoma – A rare cause of Diabetes Presented at the Association of British Clinical Diabetologists held at London in November, 2006
• Successful Treatment of Adrenocortical Carcinoma by Thalidomide. Society for Endocrinology Clinical Cases Meeting (Royal Society of Medicine) in February, 2008
• Audit of DKA management in a District General Hospital Presented at Diabetes UK, 2009
• Acute Fatty Liver due to poor diabetes control in type1 Diabetes Mellitus  Presented at the British Endocrine Society Conference – 2010
• Lithium-Induced Hypercalcemia  Presented at British Endocrine Society Conference – 2010

Panel Member for Clinical Protocol Development:

• Inpatient Diabetes Management Protocol – November 2011, Aintree University Teaching Hospital, Liverpool, U.K
• Diabetic Ketoacidosis Management Protocol  - September 2013, Royal Preston Hospital, Lancashire, U.K
• Hyperglycemia Hyperosmolar State Management Protocol – March 2012, Aintree University Teaching hospital, Liverpool, U.K
• Protocol for Initiation of GLP-1 analogues in Type 2 Diabetes management – March 2012, Aintree University Teaching Hospital, Liverpool, U.K
• Protocol for SGLT2 inhibitor initiation in Type 2 Diabetes Management – September 2013, Royal Preston Hospital, Preston, UK
• Protocol for initiation and titration of Dulaglutide in type 2 Diabetes patients –February 2015, Aintree University Teaching Hospital, Liverpool, UK
• Panel member for writing National Guidelines for Insulin use in CKD patients – New Delhi, India, November, 2016